Financials
- Market Capitalization 9.03 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
26.29
売上高対価格比率
5.97
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 959 | CORT Corcept Therapeutics Incorporated - Common Stock | 85.90 USD | -6.51% | -6.98% | +3.61% | +17.08% | 9.22 B USD | ||
| 967 | KYMR Kymera Therapeutics, Inc. - Common Stock | 110.40 USD | -7.50% | -4.18% | +27.97% | +86.80% | 9.08 B USD | ||
| 983 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.67 USD | +0.11% | +0.11% | +141.96% | +103.58% | 8.82 B USD | ||
| 987 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 314.56 USD | -3.21% | -0.17% | +16.12% | +482.63% | 8.77 B USD |